Monkeypox: Canada reports 159 cases, mostly in Quebec
The number of monkeypox cases in Canada now stands at 159.
As of Wednesday, Quebec had reported 132 cases. Twenty-one cases have been reported in Ontario, four in Alberta and two in British Columbia, according to the Public Health Agency of Canada (PHAC).
Currently there are an estimated 1,900 confirmed myoypox cases worldwide as more than 30 countries report outbreaks.
Monkeypox was first discovered in monkeys. It is caused by a type of Orthopoxvirus related to smallpox, according to the BC Center for Disease Control.
On May 19, Canada reported its first monopoly case in Montreal.
Symptoms in the first stage of menopause may include fever, chills, swelling of the lymph nodes, headache, muscle aches, joint pain, back pain and fatigue, PHAC said on its website.
In the second stage of the disease, an outbreak occurs – usually within one to three days from the flu. The rash usually starts on the face or edges, but can also affect other parts of the body.
The World Health Organization (WHO) stated that smallpox vaccines used during the eradication program may provide protection against monkeypox, adding that second- and third-generation smallpox vaccines may be helpful.
The IMVAMUNE vaccine, the Modified Vaccinia Ankara (MVA) vaccine produced by the Bavarian Nordic, has been approved to prevent monkeys, the WHO said in its vaccination and vaccination Monkeypox: Interim Guide.
“Based on the currently studied risks and benefits and regardless of where the vaccine is available, mass vaccination is not necessary, and it is not recommended to fight monocyypox at this time,” the WHO said. “The spread of monkeypox from person to person can be controlled through public health measures, which include early detection, diagnosis and care, isolation and tracking.”
Numerous studies have proven that smallpox vaccine is about 85 percent effective in preventing monkeys, according to Health Canada.
Canadian adults 18 years of age or older, who have no objection to the vaccine, may be offered the IMVAMUNE vaccine.
However, monkeypox is not a new global health problem. Since 1970, monkeypox cases have been reported in 11 African countries – Benin, Cameroon, Central African Republic, Democratic Republic of the Congo, Gabon, Cote d’Ivoire, Liberia, Nigeria, Republic of the Congo, Sierra Leone and South Sudan.
In 2003, the United States became the first non-African country to report a monkeypox outbreak.
With the WHO announcing the development of a new way to share the monopoly vaccine in more than 30 countries outside Africa, some critics fear that the vaccine will be distributed to rich countries they can afford.